99 related articles for article (PubMed ID: 10072209)
21. Sex hormone binding globulin and aging.
Caldwell JD; Jirikowski GF
Horm Metab Res; 2009 Mar; 41(3):173-82. PubMed ID: 18956301
[TBL] [Abstract][Full Text] [Related]
22. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
[TBL] [Abstract][Full Text] [Related]
23. Internalization of sex hormone-binding globulin into neurons and brain cells in vitro and in vivo.
Caldwell JD; Shapiro RA; Jirikowski GF; Suleman F
Neuroendocrinology; 2007; 86(2):84-93. PubMed ID: 17684316
[TBL] [Abstract][Full Text] [Related]
24. Regulation of sex-hormone-binding globulin production by endogenous estrogens in vitro.
Loukovaara M; Carson M; Adlercreutz H
Biochem Biophys Res Commun; 1995 Jan; 206(3):895-901. PubMed ID: 7832802
[TBL] [Abstract][Full Text] [Related]
25. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha.
Selva DM; Hammond GL
J Mol Endocrinol; 2009 Jul; 43(1):19-27. PubMed ID: 19336534
[TBL] [Abstract][Full Text] [Related]
26. A steroid-binding protein mediates estrogen-dependent inhibition of growth of MCF-7 breast cancer cells.
Tanji M; Carpenter DO
Anticancer Res; 2000; 20(4):2785-9. PubMed ID: 10953358
[TBL] [Abstract][Full Text] [Related]
27. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
28. Fibulin-1 interacts with Sex Hormone Binding Globulin and is linked to less aggressive estrogen-dependent breast cancers.
Marano F; Zunino V; Frairia R; Arvat E; Castellano I; Bosco O; Catalano MG; Fortunati N
Life Sci; 2018 Aug; 207():372-380. PubMed ID: 29940241
[TBL] [Abstract][Full Text] [Related]
29. The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG).
Fazzari A; Catalano MG; Comba A; Becchis M; Raineri M; Frairia R; Fortunati N
Mol Cell Endocrinol; 2001 Feb; 172(1-2):31-6. PubMed ID: 11165037
[TBL] [Abstract][Full Text] [Related]
30. Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions.
Low YL; Taylor JI; Grace PB; Dowsett M; Scollen S; Dunning AM; Mulligan AA; Welch AA; Luben RN; Khaw KT; Day NE; Wareham NJ; Bingham SA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):213-20. PubMed ID: 15668497
[TBL] [Abstract][Full Text] [Related]
31. [Reference values of FSH, LH, total testosterone, free testosterone, 17-beta-estradiol and SHBG in healthy children in Zaragoza].
Cortés Blanco A; Ferrández Longás A; Mayayo Dehesa E; Labarta Aizpún JI
An Esp Pediatr; 1999 Aug; 51(2):159-66. PubMed ID: 10495503
[TBL] [Abstract][Full Text] [Related]
32. Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome.
Hampl R; Snajderova M; Lebl J; Lisa L; Dvorakova M; Hill M; Sulcova J; Starka L
Endocr Regul; 2001 Mar; 35(1):17-24. PubMed ID: 11308992
[TBL] [Abstract][Full Text] [Related]
33. Nonlinear binding of sex steroids to albumin and sex hormone binding globulin.
Zeginiadou T; Kolias S; Kouretas D; Antonoglou O
Eur J Drug Metab Pharmacokinet; 1997; 22(3):229-35. PubMed ID: 9358204
[TBL] [Abstract][Full Text] [Related]
34. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
36. Use of a biotinyl-estradiol derivative to demonstrate estradiol-membrane binding sites on adherent human breast cancer MCF-7 cells.
Germain PS; Metezeau P; Tiefenauer LX; Kiefer H; Ratinaud MH; Habrioux G
Anticancer Res; 1993; 13(6A):2347-53. PubMed ID: 8297157
[TBL] [Abstract][Full Text] [Related]
37. Magnesium effect on testosterone-SHBG association studied by a novel molecular chromatography approach.
Excoffon L; Guillaume YC; Woronoff-Lemsi MC; André C
J Pharm Biomed Anal; 2009 Feb; 49(2):175-80. PubMed ID: 19095394
[TBL] [Abstract][Full Text] [Related]
38. Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3',5'-monophosphate.
Nakhla AM; Khan MS; Rosner W
J Clin Endocrinol Metab; 1990 Aug; 71(2):398-404. PubMed ID: 2166070
[TBL] [Abstract][Full Text] [Related]
39. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
40. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
